Viewing Study NCT02630368

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:27 PM
Ignite Modification Date: 2026-02-22 @ 2:31 AM
Study NCT ID: NCT02630368
Status: UNKNOWN
Last Update Posted: 2022-02-02
First Post: 2015-11-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Metronomic CP and JX-594 in Patients With Advanced Breast Cancer and Advanced Soft-tissue Sarcoma (METROmaJX)
Sponsor: Institut Bergonié
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
None Soft-tissue Sarcoma View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Soft-tissue Sarcoma View
None Advanced Breast Cancer View
None Maximum Tolerated Dose View
None Efficacy and safety View
None Immunotherapy View